老虎证券

BUZZ-CG Oncology jumps after late-stage bladder cancer therapy data

Reuters
昨天
BUZZ-CG Oncology jumps after late-stage bladder cancer therapy data

** Shares of cancer drug developer CG Oncology CGON.O rise 34% to $30

** On late Saturday, CGON said its bladder cancer therapy, cretostimogene grenadenorepvec, showed 42.3% of patients maintained complete response at 24 months for high-risk bladder cancer patients who failed previous treatments, in an ongoing late-stage study

** 97.3% of treated patients remained free from progression to more serious muscle-invasive bladder cancer at 24 months, co said

** Early data from another patient group, Cohort P, showed 90.5% of patients remained free from high-grade recurrence at both 3 and 9 months

** As of last close, stock down 22% YTD

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10